CIBC Private Wealth Group
TERN

CIBC Private Wealth Group’s Terns Pharmaceuticals TERN Stock Holding History

CIBC Private Wealth Group’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$202K Hold
5,000
– – ﹤0.01% 1184
2025
Q3 		$37.5K Hold
5,000
– – ﹤0.01% 1914
2025
Q2 		$18.6K Hold
5,000
– – ﹤0.01% 2044
2025
Q1 		$10.3K Buy
5,000
+4,000
+400% +$16.3K ﹤0.01% 2239
2024
Q4 		$5.25K Sell
1,000
-1,000
-50% -$6.77K ﹤0.01% 2455
2024
Q3 		$16.7K Buy
2,000
+1,000
+100% +$8.23K ﹤0.01% 2235
2024
Q2 		$7.53K Buy
1,000
+900
+900% +$5.45K ﹤0.01% 2392
2024
Q1 		$710 Buy
+100
New +$653 ﹤0.01% 2897

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CLGM
Capitolis Liquid Global Markets New York $15.7B AUM 30.78% 1-Year Est. Return

CIBC Private Wealth Group's TERN Position: Q4 2025 in Review

CIBC Private Wealth Group held its Terns Pharmaceuticals (TERN) position steady in Q4 2025 at 5,000 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #1184.

CIBC Private Wealth Group first reported a position in TERN in Q1 2024 and has held it in 8 quarters since. 248 funds tracked by Wall St. Rank hold TERN as of Q4 2025.

  • CIBC Private Wealth Group held 5,000 shares of Terns Pharmaceuticals worth $202K as of Q4 2025.
  • CIBC Private Wealth Group left its Terns Pharmaceuticals share count unchanged in Q4 2025.
  • Terns Pharmaceuticals made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1184 holding.
  • CIBC Private Wealth Group first reported a position in Terns Pharmaceuticals in Q1 2024 and has held it in 8 quarters since.
  • 248 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.